BioSpace News Archive

Job Trends

Astellas Receives SBTi Approval for Revised Science-Based Climate Goals to Reduce Greenhouse Gas Emissions

Astellas Pharma Inc. announced that the Science Based Targets initiative *1 has validated and approved its greenhouse gas emissions reduction targets.

January 19, 2023
·
3 min read
Business

Angle PLC Announces Appointment of Non-Executive Director

ANGLE plc, a world-leading liquid biopsy company, is delighted to announce that Joseph Eid M.D. has been appointed as a Non-Executive Director of the Company, with effect from 19 January 2023.

January 19, 2023
·
7 min read
Immunovia realigning Swedish operations with strategic priorities and its focus on the US commercialization of the IMMray™ PanCan-d test

Immunovia announced it is realigning its Swedish operations with its strategic priorities to drive R&D productivity and focus on the US commercialization of the IMMray™ PanCan-d test.

January 19, 2023
·
2 min read
Business

VectorY and Annogen Announce Research Collaboration for the Development of CNS-cell Specific Promoters

VectorY Therapeutics and Annogen announced a research collaboration for the identification of CNS-cell specific synthetic promoters for use in VectorY’s vectorized antibody programs.

January 19, 2023
·
3 min read
Policy

Conventus Flower Orthopedics Announces Expansion of its Flex-Thread™ Technology Platform with FDA Clearance of the Ulna Intramedullary Nail System

Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Food and Drug Administration 510 clearance for the Flex-Thread™ Ulna Intramedullary Nail System.

January 19, 2023
·
2 min read
Business

Scenic Biotech Strengthens Drug Discovery Expertise in Management Team with the Addition of Kristof Van Emelen

Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, announced the appointment of Kristof Van Emelen, PhD, as Vice President of Drug Discovery.

January 19, 2023
·
2 min read
Business

SeqOnce Biosciences Completes Relocation to Carlsbad, CA

SeqOnce Biosciences, Inc. is thrilled to announce it has officially completed their move into a new facility located in Carlsbad, CA.

January 19, 2023
·
1 min read
Business

Henry Schein to Webcast Fourth Quarter and Full-Year 2022 Conference Call on Thursday, February 16, 2023 at 10:00 a.m. ET

Henry Schein, Inc. announced today that it will release its fourth quarter and full-year 2022 financial results before the stock market opens on Thursday, February 16, 2023, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time.

January 19, 2023
·
2 min read
FDA

FDA Clears ‘Selux NGP System’ for Rapid Antibiotic Susceptibility Testing

Selux Diagnostics announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Next Generation Phenotyping (NGP) System.

January 19, 2023
·
2 min read
Business

Foundation Medicine Announces Global Collaboration with Boehringer Ingelheim to Advance Biliary Tract Cancer Care

Foundation Medicine Announces Global Collaboration with Boehringer Ingelheim to Advance Biliary Tract Cancer Care.

January 19, 2023
·
4 min read